In this engaging discussion, Carrie Li, a physician and statistician with over 13 years in the pharmaceutical sector, shares her insights on Clinical Development Plans (CDPs). She highlights the importance of early decision-making and cross-functional collaboration among clinical, commercial, and regulatory teams. Carrie elaborates on the differences between big pharma and startups, adaptive design strategies, and regulatory engagement with the FDA and EMA. Listeners will gain practical tips on balancing scientific rigor with business goals to advance drug development.
